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2. ABBREVIATIONS 
 
 
ASK   Atlantic salmon kidney 
Cdk   Cyclin dependent kinase 
CHSE-214  Chinook salmon embryo cell line 
CPE   Cytopathic effect 
Ct   Treshold cycle 
DHO   Dhori 
DNA   Deoxyribonucleic acid 
DMSO  Dimethyl Sulphoxide 
ds   Double-stranded  
EST   Expressed sequence tag 
FADD   Fas-associated death domain 
FBS   Fetal bovine serum 
HA   Hemagglutinin 
HE   Hemagglutinin esterase 
HEF   Hemagglutinin-esterase-fusion 
IAP   Inhibitor of apoptosis 
IFN   Interferon 
IL   Interleukin 
Inf   Influenza 
ISA   Infectious salmon anemia 
ISAV   Infectious salmon anemia virus 
M1   Matrix protein 1  
M2   Matrix protein 2 
mRNA  message RNA   
NA   Neuramidase 
NF   Nuclear factor 
NK   Natural killer 
NP   Nucleoprotein 
OD   Optical density 
PBS   Phosphate buffered saline 
PCR   Polymerase chain reaction 
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Pdcd5   Programmed cell death 5 
p.i   Post infection 
REST   Relative Expression Software Tool 
RNA   Ribonucleic acid 
RNP   Ribonucleoprotein 
RT-PCR  Reverse transcription polymerase chain reaction 
Segm   Segment  
SHK   Salmon head kidney 
SS   Staurosporine 
ss   Single-stranded 
THO   Thogoto 
TNF   Tumor necrosis factor 
TRAIL  Tumor necrosis factor-related apoptosis inducing ligand  
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3. ABSRTACT 
 
 
 Infectious salmon anemia virus (ISAV) is the causative agent of an important viral 
disease threatening the Atlantic salmon aquaculture in Norway and many other countries. 
Although its structure and pathogenesis is well described little is known about its effects on 
the expression of genes related to apoptosis in the host cell.  
Apoptosis is a genetically controlled process of cell suicide in response to a variety of 
stimuli and is considered a part of the innate immune response to virus infection, limiting the 
time and cellular machinery available for viral replication. Previous studies have shown that 
several RNA viruses induce apoptosis in host-cells. A recent study also suggests that the CPE 
observed in ISAV-infected SHK-1 and CHSE-214 cells is associated with apoptosis. 
Studies of ISAV-induced apoptosis may provide a clearer picture of the cellular 
mechanisms of viral persistence and pathogenesis in ISAV infection. In the present study we 
wanted to investigate the effect of ISAV infection on the expression of apoptosis related 
genes in Atlantic Salmon (Salmo salar L.) cells. By using a quantitative real-time PCR 
approach we analyzed the regulation of key apoptosis related genes during early stages of 
ISAV infection in vitro. Two different permissive cell lines for ISAV were used, Atlantic 
salmon head kidney (ASK) cells and salmon head kidney (SHK-1) cells.   
Our results strongly indicates that IFN-α, Mx and cIAP-1 are up regulated during 
ISAV infection in both ASK and SHK-1 cell lines. We also showed that viral mRNA 
increased steadily throughout the infection, in spite of the increased levels of IFN-α and Mx, 
indicating that these genes have little or no antiviral effect on ISAV in Atlantic salmon cells.  
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4. INTRODUCTION 
 
 
4.1 Orthomyxoviridae 
 
 The family Orthomyxoviridae (from greek orthos, “standard, correct” and myxo, 
“mucus”) contains five genera, including the influenza A, B and C viruses. A fourth genus, 
Thogotovirus, includes tick-transmitted orthomyxoviruses (Pringle 1996)and are designated 
Dhori- and Thogotoviruses. The fifth genera is suggested to be  named Aquaorthomyxovirus 
to reflect the host range of viruses (ISAV) as well as the proposed family allocation (Krossoy, 
Hordvik et al. 1999). (Figure 4.1) 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.1: Genetic distance tree drawn by the neighbour-joining method. Branch lengths are 
drawn to scale. Genetic distances were calculated based on the polymerase (PB1) sequences. Virus 
abbrevations are as follows: Inf A, influenza A/PR/8/34 (J0251); inf B, influenza B/AnnArbor/1/66 
(M20170); Inf C, influenza C/JJ/50 (M28060); THO, Thogoto (AF004987); DHO, Dhori (M65866) 
(Krossoy, Hordvik et al. 1999). 
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 Orthomyxoviridae are single-stranded, enveloped RNA viruses in which the RNA has 
a negative polarity and is segmented. The genomic RNA of negative strand RNA viruses 
serves two functions: first as a template for synthesis of messenger RNAs (mRNAs) and 
second as a template for synthesis of the antigenome (+) strand, which is a copy of the 
complete viral genome (for influenza virus, often termed template RNA or complementary 
RNA (cRNA)). Negative strand RNA viruses encode and package their own RNA 
transcriptase, but mRNAs are only synthesized once the virus has been uncoated in the 
infected cell. Viral replication occurs after synthesis of the mRNAs and requires the 
continuous synthesis of viral proteins. The newly synthesized antigenome (+) strand serves as 
the template for further copies of the (-) strand. (Lamb 2001) 
 ISAV, influenza A and B viruses have their RNA divided into 8 segments, whereas 
influenza C only has 7 segments (Mjaaland, Rimstad et al. 1997; Cox, Brokstad et al. 2004), 
and the tick-borne viruses, Dhori virus and Thogoto virus, have 6 segments (Leahy, Dessens 
et al. 1997). The most conserved orthomyxoviroid gene has been shown to be the RNA-
dependent RNA polymerase (PB1) (Lin, Roychoudhury et al. 1991). The occurrence of 
consensus regions in the RNA-dependent RNA polymerase has led to the assumption that the 
sequence similarities may be linked to the existence of a common ancestral genetic element 
bearing a polymerase function, which emerged only once during the evolution (Krossoy, 
Hordvik et al. 1999). 
 
4.1.1 Virion structure 
 
 The lipid membrane of orthomyxoviruses is derived from the plasma membrane of the 
host cell. Influenza virus A and B are distinguished by two integral membrane glycoproteins, 
hemagglutinin (HA) and neuramidase (NA), that protrude from the virion surface. HA is 
responsible for attachment of the virus to sialic acid-containing oligosaccharides on the host 
cell surface and also fusion between the viral and endosome membranes resulting in release of 
viral RNPs into the cytoplasma. The NA cleaves sialic acids and plays important roles in viral 
entry and release. Influenza C virus, by contrast, has only a single membrane glycoprotein, 
hemagglutinin-esterase-fusion protein (HEF). HEF does not recognize sialic acid, but 
facilitates binding of virus to the host by binding to oligosaccharides containing a terminal 9-
α-acetyl-N-acetylneuramidase acid. The receptor-destroying enzyme (esterase) of influenza C 
virus resides in the HEF protein, at a site distinct from that responsible for receptor binding. 
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Within the lipid envelope are the matrix (M1) protein and RNA segments, which are 
associated nucleoprotein (NP) and three large polymerase proteins, designated PA, PB1 and 
PB2 on the basis of their overall acidic or basic amino acid composition. The complexes of 
viral RNA, NP, PA, PB1 and PB2 are termed ribonucleoprotein (RNP) (Kawaoka 2001). A 
third integral membrane protein is the ion channel formed by the matrix (M2) protein in 
influenza A viruses and NB in influenza B viruses (Cox, Brokstad et al. 2004). As illustrated 
in Figure 4.2, both RNA segment 7 and 8 code for more than one protein (M1 and M2, and 
NS1 and NS2, respectively). The nonstructural protein, NS1, binds to double stranded RNA, 
preventing activation of the interferon-induced protein kinase R, suggesting a role of this 
protein in the prevention of interferon-mediated antiviral responses. NS2 associates with RNP 
through interaction with the C-terminal portion of M1 protein. (Kawaoka 2001)  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Schematic representation of an influenza A viral particle. The virion contains a lipid 
envelope in which three different types of proteins are anchored: the hemagglutinin (HA), the 
neuramidase (NA) and the M2 protein. Inside the envelope there is a protein layer constituted by the 
M1 protein (filled ring) which surrounds the viral core or ribonucleoproteins (RNPs). RNA segments 
exists in a circular conformation stabilized by base-pairing between their 3’ and 5’ ends. Eight 
different RNA segments can be found per virion. (Picture taken from 
http://www.vetscite.org/publish/articles/000041/img0002.jpg) 
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4.2 Infectious salmon anemia virus 
 
 Infectious salmon anemia (ISA) was first described as a disease entity in juvenile 
Atlantic Salmon, Salmo Salar L., in Norway in 1984 (Thorud and Djupvik 1988). ISA first 
appeared in the North Atlantic (Lovely, Dannevig et al. 1999), and was later recognized in 
salmon farms on the Atlantic coast of Canada and USA, Scotland and Faeroes (Bouchard, 
Keleher et al. 1999; Lovely, Dannevig et al. 1999). ISA outbreaks have also been reported in 
Pacific Coho Salmon (Oncorhyncus kisutch) in Chile (Kibenge, Garate et al. 2001).   
The infectious salmon anemia virus (ISAV) was determined to be the causative agent 
of infectious salmon anemia, an important disease threatening Atlantic salmon aquaculture 
industry on the Northern hemisphere (reviewed in (Rimstad and Mjaaland 2002; Kibenge, 
Munir et al. 2004)). In 1994 a long term cell line, developed from Atlantic salmon head 
kidney macrophages (SHK-1), that supported the growth of ISAV was established (Dannevig, 
Falk et al. 1995). The SHK-1 cell line allowed replication of ISAV with development of 
cytopathic effects (CPE). A reverse transcriptase polymerase chain reaction (RT-PCR) 
technique has been developed for detecting ISAV, in which a fragment of the ISAV genome 
is being amplified (Mjaaland, Rimstad et al. 1997).The pathological changes of the disease 
include exophthalmia, pale gills, ascites, hemorrhagic liver necrosis, renal interstitial 
hemorrhage and tubular nephrosis.  
The transmission of ISAV in farmed populations of Atlantic salmon will be difficult to 
control, because ISAV has shown that it can infect and replicate in wild fish like: sea trout, 
brown trout, rainbow trout, eels, herring (Clupea barengus) and Artic char (Salvelinus 
alpinus), resulting in asymptomatic, probably lifelong, carriers of the virus (Krossoy, Hordvik 
et al. 1999){Kibenge, 2004 #55. ISAV is a commercially important Orthomyxovirus and 
recurrent infectious diseases causes considerable economically losses in aquaculture farming. 
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4.2.1 Virion structure 
 
 ISAV shares several morphological, biochemical and physiochemical features with 
influenza viruses. It is the only species of the Isavirus geneus, one of the five genera of the 
family Orthomyxoviridae {Krossoy, 1999 #49}. ISA virus are enveloped particles of 90-140 
nm in diameter (Dannevig, Falk et al. 1995; Dannevig, Falk et al. 1995) with 13-15 nm long 
muchroom-shaped surface projections. These surface proteins consists of a combination of 
receptor-binding hemagglutinin and receptor-destroying enzyme activity that has been 
demonstrated to be an esterase, designated HE (Falk, Aspehaug et al. 2004). 
 The genome is composed of eight segments of linear, single-stranded negative sense 
RNA (as do the influenza A and B viruses) ranging in length from 1.0 to 2.4 kb with a total 
molecular size of approximately 14.3 kb (Clouthier, Rector et al. 2002). All the eight RNA 
segments of ISAV have been sequenced (Mjaaland, Rimstad et al. 1997; Krossoy, Hordvik et 
al. 1999; Rimstad, Mjaaland et al. 2001; Ritchie, Heppell et al. 2001; Clouthier, Rector et al. 
2002; Ritchie, Bardiot et al. 2002). The genomic segment 1 encoded product is assumed to 
correspond to PB2 of the influenza viruses. Genomic segment 2 encodes for the PB1 part of 
the viral RNA polymerase. The PB1 protein is the most conserved protein of 
orthomyxoviruses. Comparison of the ISAV PB1 protein sequence with that of other 
Orthomyxoviridae revealed amino acid identities 20.8%-24.1% (Krossoy, Hordvik et al. 
1999). The amino acid sequence encoded by the open reading frame (ORF) of segment 3 was 
identified to be the nucleoprotein (NP) (Ritchie, Heppell et al. 2001). And segment 4 encodes 
for PA, which seems to be the acidic part of the viral polymerase (Ritchie, Heppell et al. 
2001). Segment 5 encodes the glycoprotein gp50 that has been shown to be a membrane 
fusion protein which requires proteolytic cleavage to induce fusion (Aspehaug, Mikalsen et al. 
2005). Segment 6 encodes HE and segment 7 and 8 have two overlapping ORFs. This 
arrangement is similar to that of the influenza A virus. ISAV share many typical properties 
with the Orthomyxoviridae but they also have a few differences from the other 
Orthomyxoviruses, such as: they are pathogenic for aquatic species and have a lower 
optimum growth temperature, between 10 and 15 ºC. There is no virus replication at 
temperatures above 25 ºC. 
The order of the genome segments encoding the proteins in ISAV appears to differ from those 
in influenza viruses (se table 4.1). 
 
 11 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1: Comparison of genome coding assignments for Isavirus and Influenza A virus.  
PB2, PB1 and PA, polymerase; NP, nucleoprotein; HA, hemagglutinin; Gp50 is an envelope fusion 
glycoprotein (Aspehaug, Mikalsen et al. 2005); HE, hemagglutinin esterase in ISAV (Falk, 
Aspehaug et al. 2004); NA, neuramidase; M1, matrix protein (Falk, Aspehaug et al. 2004); p32, a 
structural protein of unknown function in ISAV; M2, ion channel protein; p11, protein of unknown 
status and function; NS1, non-structural protein 1; NS2, non-structural protein 2 (also known as 
nuclear export protein, NEP) 
Table taken from (Kibenge, Munir et al. 2004). 
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4.3 Apoptosis 
 
Apoptosis (derived from the Greek word for a natural process of leaves falling from 
trees) is a fundamental biological process that is implicated in early development such as 
during metamorphosis in insects and amphibians, and organogenesis in virtually all 
multicellular organisms. Apoptosis is an essential component of the homeostasis of normal 
tissue. For instance, it plays an active part in the removal of tissue between fingers and toes 
during embryonic development (Meier, Finch et al. 2000)and in the formation of T and B cell 
repertoires of the immune system by eliminating non- or self-reactive cells (Krammer 2000). 
Apoptosis also exerts a role opposite to mitosis in the maintenance of cells populations. As 
many as 10
11
 cells die in an adult human per day to ensure tissue homeostasis, and it is 
estimated that within a typical year, the mass of cells a person loses through cell death is 
almost equivalent to their entire body weight. Such death therefore probably plays an 
important role in dynamic processes such as tissue remodeling and responses to stress. 
Apoptosis is also a protective mechanism, directing lysis of virus infected cells, foreign cells 
or incipient neoplasm (Wu 2001).   
 Cell death may occur through at least two broadly defined mechanisms: necrosis or 
apoptosis (Kerr, Wyllie et al. 1972). Necrosis is a passive, catabolic, pathological cell death 
process which generally occurs in response to external toxic factors such as inflammation, 
ischemic or toxic injury. It is not thought to ever occur under physiological conditions. 
Necrosis is characterized by swelling of mitochondria, early rupture of the plasma membrane, 
dispersed chromatin and early destruction of the intact structure of the cell (Wu 2001), which 
result in spilling of cell contents causing a potentially damaging inflammatory response 
(Alberts, Johnson et al. 2002).  
By contrast, a cell that undergoes apoptosis dies neatly, without damaging its 
neighbors. Apoptosis is a form of active, metabolic, genetically encoded and evolutionary 
selected death pathway, which features characteristic morphological and biochemical 
alterations such as cell shrinkage, condensation of nuclear chromatin with internucleosomal 
fragmentation of deoxyribonucleic acid (DNA), disintegration into membrane wrapped 
fragments and exposure of phosphatidylserine residues on the cell surface (Müllauer 2006). 
Degradation of chromosomal DNA into oligonucleosome-sized fragments results in a distinct 
laddering pattern on an ethidium bromide-stained agarose gel that represents a hallmark for 
apoptosis (Wyllie 1980). The appearance of phosphatidylserine molecules on the surface of 
apoptotic cells, by a flip-flopp movement of phospholipid molecules in the lipid bilayer of the 
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plasma membrane (Martin, Reutelingsperger et al. 1995), help macrophages to recognize the 
dying cells and to eliminate them by phagocytosis. This prevents leaking of the cytoplasmic 
contents into the intercellular space, minimizing tissue inflammation, avoiding damage to 
neighboring cells and resulting in efficiently degradation of host (or viral) DNA.    
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4.3.1 Genes involved in apoptosis  
 
Many genes involved in the execution of apoptosis have been identified, and different, 
although strongly interacting, pathways of apoptosis signaling have been dissected (Reed 
2000). (Figure 4.3) 
 Extrinsic pathways use transmembrane death receptors such as Fas (CD95), tumor 
necrosis factor-related apoptosis inducing ligand (TRAIL) receptors 1 and 2, and tumor 
necrosis factor (TNF) receptors 1 and 2.  Engagement of the receptors with their cognate 
ligands leads to formation of a death-inducing signaling complex, with recruitment of the 
adapter protein FADD (Fas-associated death domain), which creates a link to initiator 
procaspases 8 and 10, proteases that contain an active-site cysteine and cleave proteins after 
certain aspartate residues. Activated caspases 8 and 10 then promote cleavage of downstream 
effector caspases 3, 6 and 7 that degrades various cellular proteins, ultimately leading to 
apoptosis. The chain of protease activation (caspases cascade) can be interrupted by inhibitor 
of apoptosis proteins (IAPs), which block the activity of caspases (Deveraux and Reed 1999).  
 An intrinsic apoptosis pathway focuses on mitochondria and is triggered by various 
types of cellular stress (e.g withdrawal of growth factors, hypoxia, cytotoxic drugs) that lead 
to a change in the permeability of the outer mitochondrial membrane with leakage of 
mitochondrial proteins into the cytosol. Cytochrome c is an important protein, which when 
released, binds to the cytosolic adapter molecule Apaf-1 and induces its oligomerization 
(Kroemer and Reed 2000). Oligomerized Apaf-1 recruits the initiator procaspase 9, which 
after activation triggers a cascade of caspases reactions. Another protein released from 
mitochondria HtrA2/Omi, has the ability to block IAPs and promotes cell death via its serine 
protease activity. Other proteins released from the mitochondria are AIF, which translocates 
to the nucleus and induces chromatin condensation and EndoG nuclease, which fragments 
DNA. 
 The mitochondrial branch of apoptosis signaling is regulated by the bcl-2 family. 
Some members of this family, like bcl-2 itself or bcl-XL, inhibit apoptosis, at least partly by 
blocking the release of cytochrome c from mitochondria. Other members of the bcl-2 family 
are not death inhibitors, but instead promote procaspase activation and cell death. Some of 
these apoptosis promoters, such as Bad, function by binding to and inactivating the death-
inhibiting members of the family, whereas others, like Bax and Bak, stimulate the release of 
cytochrome c from mitochondria.  Bax and Bak are themselves activated by other apoptosis-
promoting members of the bcl-2 family, such as Bid (Alberts, Johnson et al. 2002). Pro- and 
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antiapoptotic Bcl-2 family members form homo- and heterodimers and their relative 
concentration determines the susceptibility to apoptotic stimuli (Gross, McDonnell et al. 
1999). 
 A second intrinsic apoptosis pathway features the nuclear protein p53. The molecule 
links cell damage to cell cycle arrest and apoptosis. It is activated in the response to DNA 
damage or cell stress and arrests cells with DNA damage by promoting genes that induce cell 
cycle arrest (especially p21, which inactivates cyclin-Cdk complexes necessary for the cell to 
progress through the cell cycle) or initiates apoptosis, partially by inducing the transcription 
of proapoptotic genes like Bcl-2 associated X protein (BAX) and genes whose products 
generate reactive oxygen species (Vogelstein, Lane et al. 2000). 
 
 
 
 
 
 
 
   
 
Figure 4.3: Simplified scheme of the major apoptosis signaling pathways (see text for details). 
IAPs: inhibitor of apoptosis proteins; Cyt-c: cytochrome-c; Granz: granzyme; NK: natural killer; ROS: 
reactive oxygen species; BIRC1/2: inhibitor of apoptosis proteins (Müllauer 2006) 
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4.3.2 Genes analyzed 
 
IFN-α 
 
 Interferons are transcriptionally regulated cytokines and key players in the innate 
antiviral immune response. The transcription of IFN is induced by the presence of double 
stranded RNA and causes an antiviral state in neighboring cells (reviewed in (Bonjardim 
2005)). More details of IFN-actions are discussed in section 4.3.3. 
  
MX 
 
 Mx-proteins are interferon induced GTPases, which have an antiviral activity against a 
wide range of RNA viruses, including orthomyxoviruses. In the case of orthomyxoviruses, mx 
proteins prevent the incoming viral nucleocapsids from being transported into the nucleus, the 
site of viral transcription and replication. As a consequence, these viral components are 
trapped and sorted to locations where they become unavailable for the generation of new virus 
particles (Haller and Kochs 2002).  
p53 
 
 “intrinsic stresses” such as oncoproteins, direct DNA damage, hypoxia and survival 
factor deprivation, can initiate the intrinsic apoptotic pathway through the activation of p53. 
Activated p53 can then either initiate cell cycle arrest by promoting genes that induce cell 
cycle arrest (e.g. p21), or induce apoptosis by transcriptionally activating proapoptotic Bcl-2 
family members (e.g. Bax and Bak) and repressing antiapoptotic Bcl-2 proteins (Bcl-2, Bcl-
XL) and IAPs. p53 may also induce apoptosis by activating genes whose products generate 
reactive oxygen species (ROS) (Johnstone, Ruefli et al. 2002). 
 
cIAP-1 
 
 The inhibitor of apoptosis (IAP) family consists of a number of evolutionary 
conserved proteins first discovered in Baculoviruses. In addition to suppressing apoptotic cell 
death, IAPs are involved in an increasing number of other cellular functions, including cell 
cycle and intracellular transduction. It has been shown that cIAP-1 inhibits apoptosis by 
directly binding and inhibiting cell death proteases, caspase-3 and -7. cIAP-1 can also prevent 
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the proteolytic processing of procaspases-3, -6, and -7 by inhibiting the cytochrome-c-induced 
activation of  procaspases-9 (Chang, Cheng et al. 2006). 
   
pdcd5 
 
 Programmed cell death 5 (pdcd5) gene, previously named TF-1 apoptosis-related gene 
19 (TFAR19), is a novel apoptosis-related gene cloned in 1999 from TF-1 human leukemic 
cell line undergoing apoptosis. The human pdcd5 gene encodes a protein that shares 
significant homology with the corresponding protein of species ranging from yeast to mice. 
The level of pdcd5 protein expressed in cells undergoing apoptosis is significantly increased 
compared with control cells. The appearance of pdcd5 in the nuclei of apoptotic cells precedes 
the externalization of phosphatidylserine and fragmentation of chromosomal DNA. The 
nuclear translocation of pdcd5 is a universal event of the apoptotic process, and may be a 
novel early marker for apoptosis (Chen, Sun et al. 2001). 
    
bcl2l 
 
 The bcl2l gene encodes a Bcl-XL-like protein with antiapoptotic effects. After an 
apoptotic stimulus, Bcl-XL appears to localize primarily to the mitochondrial outer membrane 
where it might bind other apoptotic factors such as Bad and Bax or form an ion channel 
thought to maintain the integrity of the mitochondrial membrane and thus hindering the 
release of cytochrome c (Chen, Gong et al. 2001; Alberts, Johnson et al. 2002). 
  
Caspase-3 
 
 Caspases are a family of cysteine proteases that play important roles in regulating 
apoptosis. Caspase-3 is one of three highly homologous caspases (caspase-3, -6 and -7) that 
form the execution subfamily (effector caspases). It has been shown that depletion of caspase-
3 in a cell-free apoptotic system inhibited most of the downstream events, including various 
substrate cleavages, DNA fragmentation, chromatin marginalization, etc, whereas elimination 
of either caspase-6 or -7 had no effect. Thus, caspase-3 is important for the execution of 
certain, but not all, specific downstream events of apoptosis (Degterev, Boyce et al. 2003). 
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4.3.3 Viruses and apoptosis 
 
 The objectives for all viruses are to infect target cells, replicate large numbers of 
progeny virions, and spread these progeny to initiate new rounds of infections. Viruses encode 
highly efficient proteins to optimize such replication; however, target organisms possess both 
systemic and cell-based defenses to limit virus infection, including immune and inflammatory 
processes and execution of suicide of infected cells. In the face of such powerful host defense 
mechanisms, most viruses have evolved proteins that are able to inhibit or delay protective 
actions until sufficient viral yields have been produced. Such viral proteins, which have been 
created either by convergent evolution or by the capture of host sequences encoding entire 
proteins or individual functional domains, ablate the host response by targeting strategic 
points in defense pathways. In addition, some viruses appear to encode products that actively 
induce apoptosis as part of an exit strategy to enhance virus spread. 
 Multicellular organisms have a variety of host defenses against viral infection 
(Roulston, Marcellus et al. 1999). Systemically, the first line of defense is generally a cell-
mediated immune response. This involves the generation of cytokines such as interleukin 1 
(IL-1) and TNF, which activates macrophages, NK cells that induces apoptosis in infected 
cells, and neutrophils that then phagocytize and help to clear the infected cells. The second 
line of defense is mediated through the humoral immune response and involves cytotoxic T 
cells, antibodies generated from B cells, and numerous cytokines that regulate their response. 
The third level of defense exists at the cellular level. Induction of interferon by the presence 
of viral nucleic acids (usually double stranded RNA) can curtail the spread of infection by 
inducing an antiviral state in neighboring cells. Interferons (IFN) have two modes of action 
that lead to the shut down of viral protein synthesis (reviewed in (Samuel 2001)). First 
interferons lead to the activation of RNase-L that degrades viral mRNA. Second, interferons 
also induce the synthesis of PKR, a double-strand-RNA-dependent kinase. Activated PKR 
leads to a series of downstream events including phosphorylation of the translation initiator 
factor eIF-2α, activation of Nuclear Factor (NF)-κB and transcriptional induction of numerous 
pro-apoptotic genes including those encoding Fas, p53 and Bax (Gil and Esteban 2000). 
Another major outcome of IFN is the synthesis of MX protein which is a potent inhibitor of 
influenza virus replication (Penny and Stuart-Harris 2001). Se figure 4.4 for cellular responses 
to IFN signals. 
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 A critical step in viral pathogenesis is the ability of a virus to inhibit host antiviral 
responses through the inhibition of host gene expression and/or by interfering with 
programmed cell death. Viruses has developed various strategies either to promote or inhibit 
apoptosis, or even to do both at different stages in their replication cycle in the host cell 
(reviewed by (Roulston, Marcellus et al. 1999)). Influenza A virus is known to induce 
apoptosis both in vivo and in vitro in the latest stages of infection. Influenza virus infection 
induces the expression of Fas, and Fas-mediated apoptosis has been suggested as an important 
mechanism of cell death during influenza virus infection. The role of Fas in influenza A virus 
induced apoptosis is supported by the activation of caspases 8, but no caspases 9, in virus 
infected cells. The Fas expression by influenza virus or dsRNA is mediated partly by the 
dsRNA-dependent protein kinase (PKR), indicating the involvement of the host antiviral 
response in the induction of apoptosis during influenza A infection (Balachandran, Roberts et 
al. 2000). Caspase mediated cleavage of nucleocapsid prodein (NP) of human strains of 
influenza A also supports the antiviral role of apoptosis during influenza virus infection 
(Zhirnov, Konakova et al. 1999). The role of various viral proteins during influenza virus 
Figure 4.4: Functions of selected IFN-inducible proteins believed to affect virus multiplication. 
PKR kinase inhibits translation initiation through the phosphorylation of protein synthesis initiation 
factor eIF-2Aα. OAS synthetase family and the RNase L nuclease mediate RNA degradation. The 
family of MX protein GTPases appear to target viral nucleocapsids and inhibit RNA synthesis. ADAR 
which edits double-stranded RNA by deamination of adenosine to yield inosine. IFN induced expression 
of MHC class I and II antigens and NOS may contribute to the antiviral response observed within whole 
animals (Samuel 2001). 
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induced apoptosis has also been studied. It has been shown that NS1 (non-structural) protein 
is capable of inducing apoptosis when expressed in cell cultures (Schultz-Cherry, Dybdahl-
Sissoko et al. 2001). Experiments in Madin Darby canine kidney (MDCK) cells demonstrated 
that neuramidase (NA) could activate latent transforming growth factor beta to its biologically 
active form, a broad inducer of apoptosis (Morris, Price et al. 1999). Inhibitors of NA delayed 
the onset of apoptosis when added shortly after infection. Also viruses with highly active NA 
induced apoptosis in host cell than did those with less active NA (Morris, Price et al. 1999). 
Interaction of M1 (matrix) protein of influenza A virus with cellular caspase-8 suggests that 
M1 protein may have a role in virus-induced apoptosis (Zhirnov, Ksenofontov et al. 2002). A 
new influenza virus gene product, PB-F2, has also been shown to play important roles in 
influenza induced apoptosis (Chen, Calvo et al. 2001). It has been suggested that ISAV 
induces apoptosis in SHK-1 cells via activation of the caspase pathway, and that the ISAV 
putative PB2 protein and proteins encoded by RNA segment 7 bound caspase-8 specifically in 
vitro, suggesting that these viral proteins may have a role in ISAV induced apoptosis (Joseph, 
Cepica et al. 2004). 
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4.4 Real-Time Polymerase Chain Reaction 
 
The real-time, fluorescence-based reverse transcription polymerase chain reaction 
(RT-PCR) is the most sensitive method for detection of low-abundance mRNA, often 
obtained from limited tissue samples. It has become the method of choice for detecting 
mRNA (Bustin 2000), and is of particular value for expression studies in fish because 
availability of antibodies is still limited. Three diagnostic assays are in widespread use for 
ISAV diagnosis, which include virus isolation on permissive cell lines such as SHK-1 
(Dannevig, Falk et al. 1995), indirect fluorescent antibody testing (Falk, Namork et al. 1998) 
and reverse transcriptase polymerase chain reaction (Mjaaland, Rimstad et al. 1997). Of these 
assays, the RT-PCR is generally regarded as the most sensitive (Devold, Krossoy et al. 2000; 
Snow, Raynard et al. 2003). Recent development in real-time PCR technology offer the 
potential to overcome many of the limitations of conventional PCR including an improved 
sensitivity of ISAV diagnostics. Indeed, a sensitivity increase of 100-fold over conventional 
RT-PCR was recently reported using a SYBR green-based assay for the detection of ISAV 
(Munir and Kibenge 2004). 
Several factors have contributed to the transformation of this technology into a 
mainstream research tool: (i) as a homogeneous assay it avoids the need for post-PCR 
processing, (ii) a wide (> 10
7
-fold) dynamic range allows a straight forward comparison 
between RNAs that differ widely in their abundance, and (iii) the assay realises the inherent 
quantitative potential of the PCR, making it a quantitative assay as well as a qualitative assay 
(Gibson, Heid et al. 1996; Heid, Stevens et al. 1996; Ginzinger 2002). 
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4.4.1 Theory of Real-time PCR 
 
Real-time PCR is the technique of collecting data throughout the PCR reaction as it 
occurs, thus combining amplification and detection into a single step. This is achieved using 
different fluorescent chemistries that correlate PCR product concentration to fluorescence 
intensity. Reactions are characterized by the point in time (or PCR cycle) where the target 
amplification is first detected. This value is usually referred to as the cycle threshold (Ct), the 
time at which fluorescence intensity is greater than background fluorescence. Consequently, 
the greater the quantity of target DNA in the starting material, the faster a signal will appear, 
yielding a lower Ct (Heid, Stevens et al. 1996).  
 
PCR can be divided into four major phases (figure 4.5) (Tichopad, Dilger et al. 2003):  
• The linear ground phase (usually during the first 10-15 cycles) is in the beginning of 
the PCR reaction, and fluorescence emission at each cycle has not yet risen above 
background. 
• The early exponential phase is where the amount of fluorescence starts to rise above 
background. 
• The log-linear phase is where the PCR reaction reaches its optimal amplification 
period with the PCR product doubling after every cycle in ideal reaction conditions.  
• The plateau stage is reached when the reaction components become limited. The PCR-
reaction is no longer doubling its products after every cycle. 
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The 7000 System SDS Software Version 1.2.3 (Applied Biosystems) sets baseline and 
cycle threshold automatically based on the data gathered from these phases.  
During the linear ground phase baseline fluorescence is being calculated.  
The cycle threshold value (Ct) is usually set when the reaction have reached a threshold where 
it is significantly higher (usually 10 times the standard deviation of the baseline) than 
background fluorescence. This occurs in the log-linear phase where the PCR amplification is 
working ideally. This value is representative of the starting copy number in the original 
template and is used to calculate experimental results (Heid, Stevens et al. 1996). 
 
When quantifying mRNA, real-time PCR can be performed in two different ways. 
Either as a one-step reaction, where the entire reaction form cDNA synthesis to PCR 
amplification is performed in a single tube, or as a two-step reaction, where reverse 
transcription and PCR amplification occurs in separate tubes (Wong and Medrano 2005). 
The general steps performed during a real-time PCR, from RNA isolation to data 
analysis is outlined in figure 4.6. 
Figure 4.5: Phases of the PCR amplification curve. The PCR amplification curve 
charts the accumulation of fluorescent emission at each reaction cycle. Data gathered 
from these phases are important for calculating background signal, cycle threshold 
and amplification efficiency. Rn is the intensity of fluorescent emission of the reporter 
dye divided by the intensity of fluorescent emission by the passive dye (a reference 
dye incorporated into the PCR master mix to control for differences in master mix 
volume). This graph is copied from (Wong and Medrano 2005).      
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One-step real time PCR is thought to minimize experimental variation because both 
enzymatic reactions occur in a single tube. However, this method uses mRNA as a starting 
template, which is prone to rapid degradation if not handled properly. Therefore a one-step 
reaction may not be suitable in assays where the sample is tested on several different 
occasions over a period of time. One-step protocols are also reportedly less sensitive than 
two-step protocols (Battaglia, Pedrazzoli et al. 1998). 
Two-step real-time PCR separates the reverse transcription reaction from the real-time 
PCR assay, allowing several different real-time PCR assays on dilutions of a single cDNA. 
Because the process of reverse transcription has highly variable reaction efficiencies 
(Reinhold, Berkin et al. 2001), using dilutions from the same cDNA template ensures that 
reactions from subsequent assays have the same amount of template as those earlier. A two-
step protocol may be preferred when using a DNA binding dye (such as SYBR Green I) 
because its easier to eliminate primer-dimers through the analysis of melting curve 
temperatures (Tm) (Vandesompele, De Paepe et al. 2002). However, two-step protocols allow 
for increased opportunities of DNA contamination in real-time PCR, due to more sample 
handling. 
Figure 4.6: Steps performed when measuring gene expression using 
real-time PCR.  This figure is copied from (Wong and Medrano 2005).     
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4.4.2 Detection chemistries 
 
There are several different fluorescence detection chemistries available, but in this 
study we used SYBR Green I, a DNA binding dye as mentioned earlier. DNA binding dyes is 
thought to bind to the minor grove of dsDNA (figure 4.7). In its unbound state it has relatively 
low fluorescence but when bound to DNA it shows strong emission. As the dsDNA 
accumulates during PCR cycling, more dye can bind and emit fluorescence. Thus, the 
fluorescence intensity increases proportionally to dsDNA concentration (Wittwer, Herrmann 
et al. 1997).   
 
 
              
 
 
 
 
 Using DNA binding dyes is a very flexible technique because one dye can be used for 
different gene assays. 
 
PCR master mix volume has been shown to be a factor in PCR amplification 
efficiency such that differences in master mix volume in reactions using the same amount of 
starting template have different reaction efficiencies (Liu and Saint 2002). A passive reference 
dye (such as ROX) is often included in the master mix to account for subtle differences in 
PCR master mix volumes as well as non-PCR related fluctuations in fluorescence signal.  
 
 
Figure 4.7: SYBR Green I DNA binding Dye.  
SYBR Green I binding to dsDNA and emitting a 
fluorescent signal. Figure copied from (Ginzinger 
2002). 
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4.4.3 Relative Quantification 
 
 Relative quantification describes the changes in expression of the target gene relative 
to some reference group such as an untreated control or a sample at time zero in a time course 
study (Livak and Schmittgen 2001). Errors in quantification of mRNA transcripts are easily 
affected by any variation in the amount of starting material between samples. A frequently 
used strategy to compensate for these errors is to amplify, simultaneously with the target 
gene, a nonregulated housekeeping gene that serves as an internal reference against which 
other RNA values can be normalized (Karge, Schaefer et al. 1998). In this study 18S and 
EF1α where used as reference genes (Jorgensen, Kleveland et al. 2006).  
 To ensure that normalisation strategies are applied with proper statistical validity, 
mathematical models for real-time PCR quantification, such as REST 2005 (relative 
expression software tool)(Pfaffl, Horgan et al. 2002), have been developed and are used to 
analyze the real-time PCR results. The purpose of REST 2005 is to determine whether there is 
a significant difference between samples and controls, while taking into account issues of 
reaction efficiency and reference gene normalisation.  
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5. MATERIALS 
 
 
5.1 Reagents and chemicals 
 
Applied Biosystems, Warrington, UK 
• SYBR® GREEN PCR Master Mix 
 
Arcus, Oslo, Norway 
• Ethanol 
 
Bio Whittaker, Wokingham, UK 
• Fetal bovine serum (FBS, Australian orgin) 
• Gentamicin (50mg/ml) 
• Leibowitz (L-15) medium  
 
Cambrex Bio Science Rockland, ME, USA 
• FlashGelTM DNA Marker  
• FlashGelTM Loading Dye  
 
Eppendorf, Hamburg, Germany 
• Water, Molecular Biology Grade) 
 
Gibco BRL, Uxbridge, UK 
• 2-mercaptoethanol (2-ME) (50mM) 
• L-glutamine (200mM)  
• Trypsin-EDTA 
 
Merck, Darmstadt, Germany 
• HCl 
• KCl 
• KH2PO4 
• NaCl 
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• Na2HPO4 · 2H2O 
 
Sigma, St. Louise, USA 
• Staurosporine Ready Made Solution  
• DMSO  
 
 
5.2 Kits 
 
RNeasy® Mini Kit (Qiagen, MD, USA) 
RNase free DNase set (Qiagen, MD, USA) 
TaqMan® Reverse Transcription Reagents (Applied Biosystems, NJ, USA) 
FlashGel
TM
 System Kit (Cambrex Bio Science Rockland, ME, USA)  
 
 
5.3 Solutions 
 
PBS, pH 7,4 ( 4 L) 
32 g  NaCl 
0,8 g  KCl 
1,08 g   KH2PO4 
7,12 g   Na2HPO4 · 2H2O 
3950 ml Deionized water. 
 
pH adjusted to 7,4 with HCl. 
Autoclaved, and stored at + 4 ºC. 
 
20% Sucrose solution (100 ml) 
20 g   Sucrose  
ad 100 ml  Deionized water 
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5.4 Primers 
Genes Direction Sequence Amplicon Acc.no 
     
cIAP-1 a F GGCGTAATGACGACGTGAAGT  101 tc43301 
 R CCTAGGGAACCATTTGGCGT   
     
cIAP-1 b F2 GGTGGTTGTGTCGGCTCTG 101  
 R2 CTCGGCCAGCATCTCTTTCT   
     
Pdcd5 a  F AGGCCAAACAGAGGGAAACA 101 tc29121 
 R TGGCTTCACCAGAGCCAAGT   
     
Pdcd5 b  F2 AACCGACGAAAGGTGATGGA  101  
 R2 CCTGAATCCCTCCCTAAGCC   
     
bcl2l a F TTGTCAGTTGGTGCTGGAGG 101 tc29759 
 R CCAAATTGCTTCTGCCGTTC   
     
bcl2l b F2 AAGCCATTGCAAATGGGTCT  101  
 R2 TGCTGCTTTCACTGCCTCAA   
     
cIAP-1(2) a F CAGAACAGCCCGTTGCTCAT 101 BG934097 
 R CGAGCGAAGGTGGAGATACG   
     
cIAP-1(2) b F2 AGAACAGCCCGTTCCTCATG 101  
 R2 CCGAGCGAAGGTGGAGATAC   
     
Caspase 3 a F GGAATGAGCTTTCGCAATGG 101 DQ008069 
 R ACAGTCTGGTCATTGGCAACC   
     
Caspase 3 b F2 TCAGTGCAAAGGTTTACGACAGA 101  
 R2 ACACACTGACCAAGGCTGGG   
     
p53   F AAAACCCCCGGCAATAACAA 151 BG934348 
 R CTAGGACCTGAAAGCAGCACG   
     
Segm 5 F GGAAAGCCCTGCTCTGGC 51 AY853932 
 R TCCTCAAGTCTGCTTCGGGA   
 
 
Table 5.1: Real-Time PCR primers designed and used in the present study. The different 
primer sets are noted a and b. There are all together four primer set for two cIAP-1 genes (to 
separate them one is marked with “(1)”) due to changes in the Genebank late in this study. 
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Genes Dir. Sequence Amp. E-value Acc.no 
      
MX F TGATCGATAAAGTGACTGCATTCA 80 0,99 SSU66477 
 R TGAGACGAACTCCGCTTTTTCA    
      
INF-α  F CCTGCCATGAAACCTGAGAAGA 107 0,96 AY216594 
 R TTTCCTGATGAGCTCCCATGC    
      
18S  F TGTGCCGCTAGAGGTGAAATT  61 1,00 AJ427629 
 R GCAAATGCTTTCGCTTTCG    
      
EF1 α F CACCACCGGCCATCTGATCTACAA 77 0,97 AF321836 
 R TCAGCAGCCTCCTTCTCGAACTTC    
Table 5.2: Real-Time PCR primers used in the present study. (Already designed and tested by 
S.M. Jørgensen (Jorgensen, Kleveland et al. 2006)). Dir = direction; Amp = amplicon size; E-value = 
primer efficiency and Acc.no = Accession number. 
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6. METHODES 
 
 
6.1 Cell cultures 
 
ASK cells (Atlantic salmon kidney cells), kindly provided by B. Krossøy (Department 
of Fisheries and Marine Biology, University of Bergen, Norway) were cultured in Leibovitz 
L-15 medium (Cambrex Bio Sciences, Verviers, Belgium) supplemented with 50 µg µl
-1
 
gentamicin, 4 mM L-glutamine, 40 µM β-mercaptoethanol and 10% foetal bovine serum (L-
15 complete). The SHK-1 cell line (Salmon head kidney), kindly provided by B. Dannevig 
(National Veterinary Institute, Oslo, Norway), were also cultured in Leibovitz L-15, but with 
5% foetal bovine serum. Cells were routinely split 1:3 once a week and maintained at 20 ºC. 
 
 
6.2 Virus production 
 
Inoculation of ISAV (strain Glesvaer/2/90 was kindly provided by B. Dannevig, with a 
virus titer of 1×10
5.7
 TCID50 ml
-1
, which had been passaged two times in SHK-1 cells and 
stored at -80 ºC until use, was performed on SHK-1 cells grown in 500 cm
2
 cell culture flasks. 
The cell culture medium was removed, and the cells were washed twice in phosphate buffered 
saline (PBS) pH 7,4, before 20 ml ISAV inoculate, diluted 1:50 in serum-free medium, was 
added. The virus was allowed to adsorb for 4 h at 15 ºC, followed by the addition of 100 ml 
L-15 complete medium. Infection was allowed to proceed at 15 ºC for 20 days to ensure 
enough virus replication.   
 Cell culture supernatant from ISAV-infected SHK-1 cells was cleared from cell debris 
by low speed centrifugation at 4000 x g for 20 min at 4 ºC (Beckman Avanti J-25 centrifuge 
with JA-10 rotor was used).  
To further separate virus from remaining serum proteins, 4 ml 20% sucrose solution 
was applied, using a syringe (Terumo), in the bottom of six polyallomer tubes (supplied by 
Beckman), and 32 ml of the cell culture supernatant was gently poured on top of it (important  
to make sure the two layers don’t mix together). The tubes containing supernatant and sucrose 
solution were then centrifuged at 104000 x g for 2 h at 4 ºC (Sorvall Discovery 100 centrifuge 
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with Surespin 630 rotor). The supernatant and sucrose were then discarded. The sucrose step 
was repeated so all virus was pelleted and filtered through the sucrose solution. 
The six tubes containing the virus pellets were then washed two times with PBS to 
remove remaining medium and sucrose. Furthermore, 2 ml of PBS pH 7,4 was applied to one 
tube and a sonicator rod (Vibra Cell, Sonic & Materials inc., Danbury, CT, USA) was used, 
three times for 2 sec, to resuspend the pelleted virus in the PBS solution. The PBS solution 
containing the ISA virus was then moved from tube to tube, with disruption of the pelleted 
virus in every tube. The final 2 ml PBS solution containing all the virus from all six tubes, 
was then divided into 200 µl samples and stored at -80 ºC until use.     
 
 
 6.3 Infection of ASK and SHK cells 
 
 SHK and ASK cells were seeded in six-well tissue-culture plates (culture area, 9,6 
cm
2
/well)(Nunc, Roskilde, Denmark). The cells were counted and 1,5 × 10
5
 cells were seeded 
with 3 ml L-15 complete medium in each well (1,5 × 10
4 
cells/cm
2
). The cells were then 
grown for 48 h at 20 ºC before infection with ISA virus. 
 After 48 h, the medium from each well was collected of and kept for later use, before 
the wells were washed three times with PBS pH 7,4. Then 600 µl ISAV inoculate (MOI = 
0,025), diluted 1:50 in serum-free medium, was added and the plates were inoculated on a 
rock tray “The Belly Button” (Stovall Life Science Greenboro, NC, USA)   for 4 h at 15 ºC. 
The control-wells were mock-infected with 600 µl serum-free medium instead of ISAV 
inoculate.  
 After inoculation the stored medium was diluted 50:50 with serum-free medium and 
2,4 ml was added to the wells. The dishes were then sealed with PCR Adhesive Sealing 
Sheets (Eppendorf, Hamburg, Germany) and stored at 15 ºC until harvest. 
 Cells were harvested at 1, 3, 5, 7 and 9 days post infection (p.i) by collecting the cell 
medium in a 15 ml collection tube, before scraping the cell monolayer in 2 ml PBS three 
times to ensure that all infected cells are loosened and collected in the collection tube. 
The tube, containing cells suspended in PBS and medium, was then pelleted at 300 x g for 10 
min (Sorvall RC 3C Pluss). To ensure complete removal of the cell culture medium, which 
can inhibit lysis of the cells by Buffer RTL, everything but the cell-pellet were removed and 
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10 ml of PBS pH 7,4 was added. Another centrifugation at 300 x g for 10 min was then done 
before the PBS was discarded.  
The washed cell-pellet was then lysed and homogenized according to manufacturer’s 
guidelines (RNeasy® Mini Kit) and stored at -80 ºC until further RNA extraction.   
 
 
 
Figure 6.1: Six-well tissue culture plate setup for ASK and SHK infections. 
The plate setup seen above was used for both ASK and SHK. Two wells were pooled for each day to 
ensure enough cell material and a high RNA yield for further use in total RNA isolation.      
 
 
6.4 Treatment of ASK and SHK cells with Staurosporine. 
 
 SHK and ASK cells were seeded in six-well tissue-culture plates (culture area, 9,6 
cm
2
/well). The cells were counted and 1,0 × 10
6
 cells were seeded with 3 ml L-15 complete 
medium in each well (1,0 × 10
5 
cells/cm
2
).  
The cells were then grown for 24 h at 20 ºC, before 3 µl staurosporine (SS) solution 
(1mM) was added to four of the wells for both SHK and ASK. Two wells were added 3 µl 
DMSO, which is used as a solvent in the staurosporine-solution, and were used as control 
samples. Cells were harvested 24 h and 48 h, after addition of staurosporine, as described 
above in section 6.3. And the cells where then stored at -80 ºC until use. 
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Figure 6.2: Six-well tissue culture plate setup for Staurosporine treatment of ASK and SHK. 
Two wells were used for each day to ensure enough cell material and a high RNA yield for further use 
in total RNA isolation. 
 
 
6.5 RNA extraction 
 
Total RNA was isolated from treated cells using RNeasy® Mini Kit (Qiagen, MD, 
USA) according to manufacturer’s instructions. Because the RNA was to be used further in 
RT TaqMan analysis and Real-time PCR which is sensitive to very small amounts of non-
target DNA, the on-column RNase free DNase set (Qiagen, MD, USA) was also used 
according to manufacturer’s instructions to ensure digestion and removal of small residual 
amounts of DNA in the column.  
Total RNA was eluted in a final volume of 40 µl RNase-free water (Eppendorf,  
Hamburg, Germany). The quality and quantity of the purified nucleic acids were determined 
by measuring the optical density (OD) at 260 nm/280 nm (OD260/OD280). OD values were 
measured with the RNA-program in Beckman DU®530 Spectrophotometer, using 2 µl RNA-
solution diluted in 98 µl RNase-free water for each sample measurement. The RNA-solutions 
were then stored immediately at -80 ºC until RT-PCR 
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6.6 cDNA synthesis  
 
 All samples were reverse transcribed using TaqMan® Reverse Transcription reagents 
(Applied Biosystems, CA, USA) according to manufacturer’s protocol and with random 
hexamer primers. For every sample, 2 µg of total RNA was transcribed in a 100 µl reaction. 
The amount of RNA-solution needed for the reaction was calculated by using   this equation: 
 
2000 
Amount of RNA-solution used   =  
µg/ml 
=   x µl 
 
 
PCR reaction in each tube (total volume of 100 µl) also consists of: 
  
10 µl 10x RT Buffer 
22 µl MgCl2 Solution 
20 µl dNTP Mix (with dTTP) 
5 µl Random Hexamers 
2 µl RNase Inhibitor 
2,5 µl Reverse Transcriptase 
38,5 µl – amount of RNA-solution used RNase-free water 
 
All samples were reverse transcribed in Eppendorf Mastercycler gradient, using the already 
made program called SMRT18. (1
st
 cycle: annealing at 25 
º
C for 10 minutes, 2
nd
 cycle: 
polymerisation at 37 ºC for 60 minutes, 3
rd
 cycle: denaturation at 95 ºC for 5 minutes and last 
4
th
 cycle: cooling at 4 ºC for up to 60 minutes.) 
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6.7 Real-time PCR 
 
 For each infection trial, real-time PCR was performed in 96-well optical plates on an 
ABI Prism 7000 Sequence Detection system (Applied Biosystems). In each well reactions 
were conducted in a final volume of 25 µl containing 12,5 µl SYBR® GREEN PCR Master 
Mix, 5,5 µl Molecular Biology Grade Water, 1 µl forward primer, 1 µl reverse primer and 5 
µl cDNA diluted 1:10, except for a 1:1000 dilution of the cDNA used with the 18S-primers. 
Controls were conducted for each primer set, using 5 µl Molecular Biology Grade Water 
instead of cDNA. Each reaction was done with two parallel’s (same reaction in two wells) to 
ensure that both samples showed the same results, and that no unwanted contamination had 
interfered with the reaction in any of the wells.    
18S and EF1α, which are considered as valid housekeeping genes and are relative stable 
during infection, were used as reference genes (Jorgensen, Kleveland et al. 2006). 
Primers for ISAV segment 5 were also used to verify that the cells were infected properly.  
 PCR parameters were 50 ºC for 2 min, 95 ºC for 10 min, followed by 40 cycles of 95 
ºC for 15 s, 60 ºC for 1 min. 
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 1 2 3 4 5 6 7 8 9 10 11 12 
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Bl
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Bl 
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Bl 
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10
-1
 
P53 
D 5 
10
-1
 
Segm5 
D 5 
10
-1
 
cIAP 
D 5 
10
-1
 
Pdcd5 
D 5 
10
-1
 
Bcl2l 
D 5 
10
-1
 
cIAP(2) 
D 5 
10
-1
 
Casp3 
D 5 
10
-1
 
 
C 18S 
D 7 
10
-3
 
EF1α 
D 7 
10
-1
 
IFNα 
D 7 
10
-1
 
MX 
D 7 
10
-1
 
P53 
D 7 
10
-1
 
Segm5 
D 7 
10
-1
 
cIAP 
D 7 
10
-1
 
Pdcd5 
D 7 
10
-1
 
Bcl2l 
D 7 
10
-1
 
cIAP(2) 
D 7 
10
-1
 
Casp3 
D 7 
10
-1
 
 
D 18S 
D 7 
10
-3
 
EF1α 
D 7 
10
-1
 
IFNα 
D 7 
10
-1
 
MX 
D 7 
10
-1
 
P53 
D 7 
10
-1
 
Segm5 
D 7 
10
-1
 
cIAP 
D 7 
10
-1
 
Pdcd5 
D 7 
10
-1
 
Bcl2l 
D 7 
10
-1
 
cIAP(2) 
D 7 
10
-1
 
Casp3 
D 7 
10
-1
 
 
E 18S 
D 9 
10
-3
 
EF1α 
D 9 
10
-1
 
IFNα 
D 9 
10
-1
 
MX 
D 9 
10
-1
 
P53 
D 9 
10
-1
 
Segm5 
D 9 
10
-1
 
cIAP 
D 9 
10
-1
 
Pdcd5 
D 9 
10
-1
 
Bcl2l 
D 9 
10
-1
 
cIAP(2) 
D 9 
10
-1
 
Casp3 
D 9 
10
-1
 
 
F 18S 
D 9 
10
-3
 
EF1α 
D 9 
10
-1
 
IFNα 
D 9 
10
-1
 
MX 
D 9 
10
-1
 
P53 
D 9 
10
-1
 
Segm5 
D 9 
10
-1
 
cIAP 
D 9 
10
-1
 
Pdcd5 
D 9 
10
-1
 
Bcl2l 
D 9 
10
-1
 
cIAP(2) 
D 9 
10
-1
 
Casp3 
D 9 
10
-1
 
 
G             
H             
Table 6.1: Example of Real-Time PCR plate setup for one infection trial. 
Primers displayed in bold, cDNA dilution showed in italic and the number of days the cells were 
harvested post infection (p.i) displayed in the middle. (D 1 = 1 day p.i, D 3 = 3 days p.i, etc).  
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6.8 Primer Design 
 
The genes used as the base for primer design were found at The Gene Index Project 
(http://compbio.dfci.harvard.edu/tgi/), by searching the Atlantic salmon (Salmon salar), 
Catfish (Ictalurus punctatus) and Zebrafish (Danio rerio) gene indices for genes related to 
apoptosis. Genes of interest were then compared to ESTs (Expressed Sequence Tags) from 
the Atlantic salmon gene bank, using Blastn (http://compbio.dfci.harvard.edu/tgi/cgi-
bin/tgi/Blast/index.cgi)  
 Real-time PCR primers (Table 5.1) were then designed manually based on Primer 
Express 2.0 software guidelines (Applied Biosystems) and synthesised by either Invitrogen 
(CA, USA) or ProOligo (Paris, France). For each gene, 2 different primers were designed and 
synthesised to ensure that at least one of them worked satisfactory. Other primers used in this 
study, had already been designed and tested by Jørgensen S.M (Jorgensen, Kleveland et al. 
2006)(Table 5.2). 
 
 
6.9 Primer efficiency tests 
 
 Primer efficiency of the new primers was tested, using real-time PCR carried out with 
10-fold dilutions of cDNA. Controls (no cDNA) and 1:1, 1:10
1
, 1:10
2
 and 1:10
3 
dilutions were 
used for each primer set. Ct- values from the results were then exported to Sigmaplot 8.0 and 
linear regression graphs were made by plotting Ct-values on the y-axis and log concentrations 
of the cDNA on the x-axis.  
R
2
 was then calculated to see how well the linear relationship between Ct values and 
log concentrations corresponded. The slope of the graph was then calculated and 
amplification efficiency of the reactions was then calculated using the following formula: 
(Rasmussen 2001) 
 
Exponential amplification = 10 
(-1/slope)
 
Efficiency = [10 
(-1/slope)
] - 1 
 
Where maximal efficiency (1) means that every single template is replicated in each 
cycle. 
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All primers were also tested for the possibility of primer dimers and unspecific 
products, by analyzing melting curves for the real-time PCR reactions for every primer set. 
 
      
6.10 Primer amplification products tests 
 
 The real-time PCR products were tested by agarose gel electrophoresis, by comparing 
theoretical amplicon size (table 5.1) to obtained fragment size. Agarose gel electrophoresis 
was done with the FlashGel
TM
 System Kit, delivered by Cambrex Bio Science Rockland, ME, 
USA.  
  Each sample well was loaded with 7 µl deionized water. One well was then added 5 
µl FlashGel
TM
 DNA Marker (band sizes: 100 / 200 / 300 / 500 / 800 / 1250 / 2000 / 4000 bp) 
and the wells for the samples were added a mix of 1 µl DNA solution and 4 µl FlashGel
TM
 
Loading Dye. The power supply was then set to 150 V constant voltages, and the gel was run 
until desired separation was obtained.     
 The fragments on the FlashGel
TM
 Cassette were then illuminated by UV-light using 
BioRad Gel Doc 1000 Darkroom. The results were then viewed and pictures were taken with 
Multi-Analyst Version 1.1.  
   
 
6.11 Real-time PCR data analysis 
 
 Data handling was done according to the ABI Prism 7000 Sequence Detection System 
User Manual and baseline and cycle threshold (Ct) were set automatically by ABI Prism 7000 
System Software for each PCR-reaction. High Ct-values (Ct > 35) were discarded manually, 
as were reactions with low fluorescence compared to the background fluorescence 
(fluorescence < 4000).  
 To calculate the relative expression of the target genes, Ct-values for target genes and 
reference genes were analyzed using the Relative Expression Software Tool (REST©) (Pfaffl, 
Horgan et al. 2002). Results from REST were then exported to Excel and relative expression 
graphs were made of the target genes for each infection trial over time. 
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7. RESULTS 
 
 
7.1 Primer Tests 
 
 Note that the cIAP-1 gene has two different primer sets, and therefore have been 
analyzed twice in this study. Late in this study the tentative consensus with accession number 
tc29339, was spilt into two new tentative consensus sequences with accession number 
tc57717 and tc43301. By aligning the old sequence with the two new sequences, using bl2seq 
(http://www.ncbi.nlm.nih.gov/blast/bl2seq/wblast2.cgi), and comparing this to the starting 
point for the primers (obtained from Primer Express 2.0), we discovered that the primer set 
for tc29339 was located on the new tc43301 sequence which is highly similar (92% hit 
coverage) to the cIAP-1 gene in Catfish.  
      
7.1.1 Primer efficiency testing 
 
The efficiency of a PCR reaction can be deducted by the slope of a standard curve 
according to equation: Efficiency = [10 
(-1/slope)
] – 1 (Rasmussen 2001) 
The maximum efficiency in PCR is 1, where every PCR product is replicated in every cycle. 
The minimum value is 0, corresponding to no amplification. 
To calculate primer efficiency, real-time PCR were done with cDNA obtained from 
untreated SHK cells. For each primer-set, a control (no cDNA) and 10-fold dilutions of cDNA 
ranging from 1:1 to 1:10
-3
 were used. Figure 7.1 shows an amplification plot of the PCR 
reactions for the cIAP-1a primers set. Amplification plots for the other primer set are not 
shown.   
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 High Ct-values (Ct > 35) were discarded manually, and the results were exported to 
Sigmaplot 8.0. Linear regression graphs for each primer set are displayed below (Figure 7.2 a-
f).  
 
cIAP-1a
Log Dilution
-3,5 -3,0 -2,5 -2,0 -1,5 -1,0 -0,5 0,0
C
t
20
22
24
26
28
30
32
34
Slope = -3,316
r ² = 0,9968
 
cIAP-1b
Log Dilution
-3,5 -3,0 -2,5 -2,0 -1,5 -1,0 -0,5 0,0
C
t
20
22
24
26
28
30
32
34
Slope = -3,2855
r ² = 0,9987
 
 
 
 
 
Figure 7.1: Real-time amplification plot of 10 fold serial dilutions. 7000 System SDS 
Software Amplification plot for the cIAP-1a primer set, with cDNA dilutions ranging 
from 1:1 to 1:10
-3
. Note that the dilution containing the highest cDNA concentration 
exhibits fluorescence earlier than the one with the second highest concentration and so on.  
Figure 7.2 a: Linear regression plots for cIAP-1. The two 
different primer sets are noted a and b. The graphs show the 
relationship between Ct-values and log-concentrations. 
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pdcd5a
Log Dilution
-3,5 -3,0 -2,5 -2,0 -1,5 -1,0 -0,5 0,0
C
t
20
22
24
26
28
30
32
34
Slope = -3,7345
r ² = 0,9983
 
pdcd5b
Log Dilution
-3,5 -3,0 -2,5 -2,0 -1,5 -1,0 -0,5 0,0
C
t
18
20
22
24
26
28
30
32
Slope = -3,3820
r ² = 0,9987
 
 
 
 
 
 
 
bcl2la
Log Dilution
-2,5 -2,0 -1,5 -1,0 -0,5 0,0
C
t
22
24
26
28
30
32
Slope = -3,5050
r ² = 0,9925
 
bcl2lb
Log Dilution
-3,5 -3,0 -2,5 -2,0 -1,5 -1,0 -0,5 0,0
C
t
24
26
28
30
32
34
36
Slope = -3,1420
r ² = 0,9979
 
 
 
 
 
Figure 7.2 b: Linear regression plots for pdcd5. The two 
different primer sets are noted a and b. The graphs show the 
relationship between Ct-values and log-concentrations. 
Figure 7.2 c: Linear regression plots for bcl2l. The two different 
primer sets are noted a and b. The graphs show the relationship 
between Ct-values and log-concentrations. 
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cIAP-1(2) a
Log Dilution
-2,5 -2,0 -1,5 -1,0 -0,5 0,0
C
t
26
28
30
32
34
36
Slope = -3,3857
r ² = 0,9937
 
cIAP-1(2) b
Log Dilution
-2,5 -2,0 -1,5 -1,0 -0,5 0,0
C
t
28
30
32
34
36
38
Slope = -3,3600
r ² = 0,9974
 
 
 
 
 
 
 
 
 
 
Caspase 3a
Log Dilution
-3,5 -3,0 -2,5 -2,0 -1,5 -1,0 -0,5 0,0
C
t
22
24
26
28
30
32
34
36
Slope = -3,569
r ² = 0,9985
 
Caspase 3b
Log Dilution
-3,5 -3,0 -2,5 -2,0 -1,5 -1,0 -0,5 0,0
C
t
22
24
26
28
30
32
34
36
38
Slope = -3,799
r ² = 0,9954
 
 
 
 
 
Figure 7.2 d: Linear regression plots for cIAP-1(2). The two 
different primer sets are noted a and b. The graphs show the 
relationship between Ct-values and log-concentrations. 
Figure 7.2 e: Linear regression plots for Caspase 3. The two 
different primer sets are noted a and b. The graphs show the 
relationship between Ct-values and log-concentrations. 
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p53
Log Dilution
-3,5 -3,0 -2,5 -2,0 -1,5 -1,0 -0,5 0,0
C
t
18
20
22
24
26
28
30
Slope = -3,313
r ² = 0,9985
 
 
 
 
 
 
 For each reaction series, there was high correlation between cycle number and dilution 
factor ( r
2
 = 1 ± 0,005), and for each gene there was at least one primer set with a slope value 
close to the optimum theoretical value of -3,32 (Snow, McKay et al. 2006).  
The slope value for each primer set was then used in the efficiency-equation, and results are 
displayed in Table 7.1.   
 
 
Primer set Slope E-value 
   
cIAP-1 a -3,32 1,00 
cIAP-1 b -3,29 1,01 
   
pdcd5 a -3,73 0,85 
pdcd5 b -3,38 0,98 
   
bcl2l a -3,51 0,93 
bcl2l b -3,14 1,08 
   
cIAP-1(2) a -3,39 0,97 
cIAP-1(2) b -3,36 0,98 
   
Caspase 3 a -3,57 0,91 
Caspase 3 b -3,80 0,83 
   
p53 -3,31 1,00 
Table 7.1: Efficiency values calculated for the primers used in present study. 
 
Figure 7.2 f: Linear regression plot for p 53. The graph shows 
the relationship between Ct-values and log-concentrations. 
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7.1.2 Melting curve analysis (elimination of primer dimers)  
 
 DNA binding dyes, such as SYBR Green, detect all dsDNA including primer dimers 
and other undesired products. The specificity of detection is therefore dependent on the 
specificity of the amplification. However this problem can be solved by analyzing the melting 
curves of the PCR reaction.  
 Plotting fluorescence as a function of temperature as the thermal cycler heats through 
the dissociation temperature of the product gives a DNA melting curve. The shape and 
position of this DNA melting curve are functions of the GC/AT ratio, length, and sequence 
and can be used to differentiate amplification products separated by less than 2 ºC in melting 
temperature (Ririe, Rasmussen et al. 1997). 
 The melting curve of the cIAP-1a PCR products is shown in figure 7.3. Melting curves 
were analyzed for every primer set, and indicated a single melting peak similar to the one in 
figure 7.3, suggesting that amplification products were specific (data not shown).        
 
 
 
 
 
 
 
 
 
 
Figure 7.3: Melting peak of cIAP-1a PCR products. A single melting peak (Tm) 
at approximately 82 ºC, indicating that the amplification was gene-specific. X-
axis displays temperature and Y-axis (derivate) displays change in fluorescence   
(-dF/dT).  
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Based on the results from both efficiency testing and melting curve analysis, the best 
primers for each gene were picked out for further use in the infection and Staurosporine trials. 
 
The primers selected for further use were:  
• cIAP-1 a 
• pdcd5 b 
• bcl2l a 
• cIAP-1(2) b  
• Caspase 3 b 
• p53 
 
Both caspase 3a and b primers were used in the first infection trials, but the PCR-reactions 
with the caspase 3a primer resulted in very high Ct-values (above 35). This was probably due 
to personal errors (e.g. pipetting errors when loading the 96-well plate). To be able to 
compare results from different infection trial, the Caspase 3b primer set, which resulted in 
better Ct-values in the infection trials, was chosen for further use.  
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7.1.3 Gel electrophoresis of amplicons 
 
As described in (Lekanne Deprez, Fijnvandraat et al. 2002), PCR amplification 
products should also be tested by agarose gel electrophoresis to ensure primer specificity. All 
amplicons were run on an agarose gel, and the obtained fragment sizes corresponded to the 
theoretical amplicon sizes displayed in Table 5.1. Gel electrophoresis results are shown in 
Figure 7.4. 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
Figure 7.4: Gel electrophoresis of the real-time PCR 
products of the primers. Lane M contains FlashGel
TM
 DNA 
Marker (band sizes: 100/200/300/500/800/1250/2000/4000 bp). 
Lanes 1-7 represent amplification products from p53, Segm5, 
cIAP-1a, pdcd5b, bcl2la, cIAP-1(2) b and Caspase3b, 
respectively. The 100 bp band is marked with a red line. The 
agarose gel was visualized under UV-light and picture was 
taken with Multi-Analyst Version 1.1.   
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7.2 Gene expression in ASK and SHK cells after treatment with 
staurosporine 
 
 Both ASK and SHK cells were treated with staurosporine as described in section 6.4. 
Staurosporine caused a rapid development of cytopathic effect (CPE) in both cell lines. After 
the first 24 hours, the cells had already “shrinked” from a flattened morphology, to a more 
rounded up structure. Many of the cells had also detached from the cell-monolayer. After 48 
hours of SS treatment almost all of the cells had detached from the cell-monolayer. 
All reactions for both SHK and ASK treated with staurosporine, showed high 
fluorescence, good parallels and low Ct-values. None were discarded. The graphs made in 
excel based on relative expression levels calculated in REST are displayed below: 
 
7.2.1 SHK cells treated with staurosporine 
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Figure 7.5: Relative expression of INF α, MX, p 53, cIAP-1, pdcd 
5, Bcl2l, cIAP-1(2) and Caspase 3. 
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7.2.2 ASK cells treated with staurosporine 
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Summary of results from cells treated with staurosporine 
 
 Staurosporine is a general inhibitor of many protein kinases, including protein kinase 
C, A and G, and is commonly used to induce apoptosis in cell-cultures (Mannherz, Gonsior et 
al. 2006). We wanted to compare changes in gene expression from cells infected with ISAV 
to cells treated with staurosporine, to see if the changes observed in the ISAV infected cells 
were a result of the ILA virus infection and not just a general change due to the apoptosis. 
 Unfortunately, the cells treated with staurosporine did not show any significant 
regulation of any genes of interest and will therefore not be comparable to the ISAV infected 
cells. In previous staurosporine experiments done earlier in this study, we had some problems 
with extracting enough RNA for cDNA synthesis from the treated cells (data not shown). 
This, together with the relative expression results, indicates that staurosporine, used in 
concentrations of 1µM, might be toxic to both ASK and SHK cells, leaving the cells no time 
to regulate their gene expression. A lower concentration of staurosporine might therefore be 
preferable in future studies with staurosporine treatment of ASK and SHK cells. 
 
Figure 7.6: Relative expression of INF α, MX, p 53, cIAP-1, pdcd 
5, Bcl2l, cIAP-1(2) and Caspase 3. 
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7.3 Viral replication 
 
 To monitor viral replication by means of increased viral mRNA levels of ISAV 
segment 5 (encoding a membrane fusion protein called gp50), real-time PCR was performed 
on cDNA synthesized from total RNA samples of SHK and ASK cells at 1, 3, 5, 7 and 9 days 
post infection. Figure 7.7 shows relative expression levels of segment 5 in SHK cells 
(infection trial 3 and 4 in section 7.4.1) calculated relative to day 1 post infection. 
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 As figure 7.7 shows, transcription of ISAV segment 5 increased steadily throughout 
the infection, indicating an increasing viral replication in SHK cells after infection. 
Transcription of Segment 5 was also analyzed on ASK cells and showed similar results of 
increasing viral replication during infection (data not shown). Increasing viral replication in 
ASK cells have also been observed in other studies (Jorgensen, Lyng-Syvertsen et al. 2006). 
   
 
 
 
 
Figure 7.7: Relative mRNA transcription of ISAV segment 5 at 1, 
3, 5, 7, and 9 days p.i. Relative transcription levels are calculated in 
REST for D3-D9. Relative expression of day 1, which all other days 
are calculated relative against, are manually set to 1.    
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7.4 Gene expression in ASK and SHK cells after ISAV infection 
 
 Both SHK and ASK cells were infected with ISAV as described in section 6.3. Note 
that in infection trials 1 and 2 for SHK and trial 1 for ASK, samples were not taken at day 1 
post infection.   
ISA virus infected and replicated in both SHK and ASK cells, and caused acute infections and 
development of cytopathic effect (CPE) in both cell lines. The CPE first appeared at 7 days 
p.i, with detachment of the infected cells from the plastic cell culture plate. At day 9 p.i, we 
could see a slight change in the morphology of some cells by changing from a flattened to a 
more rounded up structure. More cells had also detached and the cell monolayer with the 
infected cells was much less dense than the cell monolayer in the mock-infected wells. 
 All infection trials were analyzed with two housekeeping genes, 18s and EF1-α, both 
validated by Jørgensen, S.M, for use as reference genes in real-time PCR reaction studies in 
Atlantic salmon (Jorgensen, Kleveland et al. 2006). Unfortunately, some of the PCR reactions 
with 18S showed varying results, with either high Ct-values or poor parallels, and had to be 
discarded. Relative mRNA transcription levels of the genes were therefore calculated relative 
to levels in mock-infected cells, and normalized to the expression of EF1-α.  
Listed below are the infection trials done on both SHK and ASK. The results from 
real-time PCR were then exported and analyzed in REST. Graphs were then made from these 
results by plotting expression levels for every day p.i for each gene in excel.  
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7.4.1 SHK cells infected with ISAV 
 
 SHK cells used in infection trial 1 and 2 had been split between 80 to 90 times (80-90 
passages), and the cells used in infection trial 3 and 4 had been split between 50 to 60 times 
(50-60 passages). After inspection of every PCR-reaction some samples were omitted from 
the data analysis:   
 
Infection trial 1:  
• The component-graphs for the IFN-α reactions showed very low fluorescence 
compared to background fluorescence, and was therefore discarded.  
• The cIAP-1(2) was also discarded for the same reason.  
Infection trial 2: 
• The component-graphs for the IFN-α reaction showed very low fluorescence 
compared to background fluorescence, and was therefore discarded. 
Infection trial 3: 
• One of the parallels for both cIAP-1 and Caspase 3 at day 7 was deleted. 
Infection trial 4: 
• One of the parallels for both cIAP-1 and bcl2l at day 7 was deleted. 
 
Possible reasons for these failed reactions may be personal errors like, pipetting errors when 
loading the 96-well plate, contamination in some of the wells before the real-time PCR or 
errors during mixing of reagents.   
 The graphs made in excel based on relative expression levels calculated in REST are 
displayed below: 
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Infection trial 1 
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Infection trial 2 
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Figure 7.9: Relative expression of MX, p 53, cIAP-1, pdcd 5, Bcl2l , 
cIAP-1(2) and Caspase 3. 
 
Figure 7.8: Relative expression of MX, p 53, cIAP-1, pdcd 5, Bcl2l 
and Caspase 3. 
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Infection trial 3 
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Figure 7.10b: Relative expression of MX, p 53, cIAP-1, pdcd 5, 
Bcl2l, cIAP-1(2) and Caspase 3. 
 
Figure 7.10a: Relative expression of INF α. 
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Infection trial 4 
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Figure 7.11a: Relative expression of INF α and cIAP-1 
 
Figure 7.11b: Relative expression of MX, p 53, pdcd5, Bcl2l, 
cIAP-1(2) and Caspase 3 
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Summary of results with SHK cells 
 
 The relative expression studies (trial 1 and 2) done in cell-lines of high passages (80-
90), showed little regulation of the target genes. Previous expression studies done on high 
passage cell-lines early in this study indicated that cells after a certain amount of passages 
looses the ability to express and regulate certain genes (data not shown). Rishovd, AL also 
experienced that the cells used in the early infection trials lost the ability to express some 
genes (unpublished results). Previous expression studies done in ASK and SHK cell lines 
have used cells of low passages (40-60) (e.g. (Fast, Ross et al. 2005; Jorgensen, Lyng-
Syvertsen et al. 2006)), and thus seems to be of some importance to cell gene expression 
ability. Compared to the expression results obtained from cells of lower passages, there is a 
clear loss of expression and regulation in these cells and the results from trial 1 and 2 will 
therefore not be analyzed any further. Cells with lower passages are also more susceptible to 
infection.   
 The relative expression studies done on cells of lower passages (50-60), showed more 
regulation of the target genes in response to ISAV infection. Figure 7.12 shows the mean 
relative expression and standard deviations of infection trials 3 and 4, at day 7 post infection.  
 
 
 
 
 
Figure 7.12: Relative expression of target genes in SHK cells at 
day 7 p.i. Expression is calculated in REST relative to mock-infected 
cells and normalized to EF1-α.  
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Day 7 p.i was chosen because of the general mRNA shut-off induced by ISAV under 
these experimental conditions (Jorgensen, Lyng-Syvertsen et al. 2006). This is a crucial point 
because real-time PCR data are normalized against housekeeping genes that are influenced by 
this shut-off and this will likely affect the results of target gene quantification. To ensure that 
the cell still exhibits a normal gene expression and regulation, and that the mRNA shut-off not 
had gone too far we focused on the results at day 7 p.i.   
All infection trials showed a general down regulation of mRNA levels as the days of 
infection proceeded. Cycle threshold values (Ct) typically increased 2-4 values from day 1 to 
day 9 for all the genes (data not shown). 
 
When looking at the net regulation compared to the uninfected samples using EF1-α as 
a calibrator, IFN-α increased strongly from day one to a 42 fold unregulated level at day 7 
post infection.  
As a result of this, an induction of the IFN-inducible antiviral Mx gene was also 
observed at day 7 p.i, to a 2,5 fold level compared to uninfected samples.  
Both primer pairs (named cIAP-1 and cIAP-1(2)) for the cIAP-1 gene, resulted in a net up 
regulation of gene expression to a 2 and 2,2 fold increase in expression respectively. None of 
the other genes seems to be either up or down regulated to a significant extent.  
Although the results above are not statistically significant, due to small sample size, the 
results strongly indicate an up regulation of IFN, Mx and cIAP-1. 
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7.4.2 ASK cells infected with ISAV 
 
 ASK cells used in infection trial 1 had been split between 110 to 120 times (110-120 
passages), and the cells used in infection trial 2 and 3 had been split between 55 to 65 times 
(55-65 passages). After inspection of every PCR-reaction some samples were omitted from 
the data analysis: 
 
Infection trial 1: 
• The parallels for IFN-α at day 7 were discarded because of poor parallels.  
Infection trial 2: 
• The component-graphs for the MX reactions in the control showed very low 
fluorescence compared to background fluorescence. Because relative mRNA 
transcription levels are calculated relative to levels in the mock-infected cells 
(control), all MX reactions had to be discarded. 
Infection trial 3: 
• All reactions showed high fluorescence, good parallels and low Ct-values. None were 
discarded. 
 
Possible reasons for these failed reactions may be personal errors like, pipetting errors 
when loading the 96-well plate, contamination in some of the wells before the real-time PCR 
or errors during mixing of reagents.   
 The graphs made in excel based on relative expression results calculated in REST are 
displayed below: 
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Infection trial 1 
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Infection trial 2 
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Figure 7.13: Relative expression of IFN α, MX, p 53, cIAP-
1, pdcd5, Bcl2l, cIAP-1(2) and Caspase 3 
Figure 7.14a: Relative expression of IFN α 
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Infection trial 3 
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Figure 7.14b: Relative expression of p 53, cIAP-1, pdcd 5, Bcl2l, 
cIAP-1(2) and Caspase 3. 
 
Figure 7.15a: Relative expression of IFN α and MX. 
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Summary of results with ASK cells 
 
 As with the SHK infection trial, the relative expression studies (trial 1) done in cell-
lines of high passages (110-120), showed little regulation of the target genes, and will 
therefore not be analyzed any further. 
 The relative expression studies done on cells of lower passages (55-65), showed more 
regulation of the target genes in response to ISAV infection. Figure 7.16 and 7.17 shows the 
mean relative expression and standard deviations of infection trials 2 and 3, at day 7 post 
infection. 
 
Figure 7.15b: Relative expression of p 53, cIAP-1, pdcd 5, Bcl2l, 
cIAP-1(2) and Caspase 3. 
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 7 days post infection was chosen for the same reasons discussed in section 7.3.1. 
These results will also be more comparable to the data obtained in SHK cells when analyzed 
at the same time post infection. 
A general mRNA shut-off was also observed in ASK cells as the infection proceeded.  
Cycle threshold values (Ct) typically increased 2-4 values from day 1 to day 9 for all the 
genes, which is normal during infection (data not shown). 
 
 When looking the net regulation of gene expression in cells 7 days post infection 
compared to the uninfected samples and normalized to EF1-α, a strong up regulation of IFN is 
observed (535 fold up regulation). This high number is due to high differences in relative 
expression of IFN between the two infection trails. Infection trial 2 has a 817 fold up 
regulation compared to 253 fold up regulation in trial 3. It’s not easy to establish why these 
high aberrations occur, but personal errors before real-time PCR may be one explanation. In 
spite of these differences, the data clearly indicates an up regulation of IFN. 
Figure 7.16: Relative 
expression of IFN-α and Mx 
in SHK cells at day 7 p.i. 
Expression is calculated in 
REST relative to mock-
infected cells and normalized 
to EF1-α.  
Figure 7.17: Relative expression of target genes in 
SHK cells at day 7 p.i. Expression is calculated in REST 
relative to mock-infected cells and normalized to EF1-α.  
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 As a result of this up regulation Mx also have a 26 fold up regulation compared to 
mock-infected cells. This number is only taken from one infection trial, because the Mx 
reactions were discarded from trial 2, and figure 7.16 therefore shows no standard deviation.    
 Both primer pairs (named cIAP-1 and cIAP-1(2)) for the cIAP-1 gene, resulted in a net 
up regulation of gene expression to a 2,5 and 8 fold increase in expression respectively. This 
corresponds well to the up regulation already seen in SHK cells.  
 In ASK cells both pdcd5 and Caspase 3 also had a slight up regulation of 2,4 and 2,6 
respectively. Pdcd5 only show up regulation in infection trial 2, and no up regulation in trial 
3, which might indicate the up regulation in trial 2 is due to personal errors. Caspase 3 on the 
other hand shows a slight up regulation in both infection trials. All though this does not 
correspond to the results from SHK cells, it might indicate that caspase3 is up regulated in 
ASK cells.  
 Although the results above are not statistically significant, due to small sample size, 
the results strongly indicate an up regulation of IFN, Mx and cIAP-1.  
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8. DISCUSSION 
 
 
 Apoptosis is a genetically controlled process of cell suicide in response to a variety of 
stimuli. Apoptosis is considered a part of the innate immune response to virus infection, 
limiting the time and cellular machinery available for viral replication (Thompson 1995). 
There are several ways by which viruses might activate the apoptotic pathway. Some viruses 
do so through direct action of specific viral proteins, such as adenovirus E1A protein 
(Roulston, Marcellus et al. 1999). Other viruses induce apoptosis indirectly through their 
effects on cellular functions, for example by shutting down protein synthesis (Hasnain, 
Begum et al. 2003) or by activating pro-apoptotic proteins, such as upregulation of Fas which 
can be activated by the dsRNA-activated PKR during influenza virus infection (Balachandran, 
Roberts et al. 2000).  
 
Previous studies have shown that several RNA viruses induce apoptosis in host-cells. 
Influenza virus infection induces apoptosis in many cell types, e.g. HeLa and Madin-Darby 
canine kidney (MDCK) cells, lymphocytes, neutrophils and bronchiolar epithelial cells 
(Brydon, Smith et al. 2003). Infectious pancreatic necrosis virus induces apoptosis in cultured 
fish cells (Santi, Sandtro et al. 2005). A recent study also suggests that the CPE observed in 
ISAV-infected SHK-1 and CHSE-214 cells is associated with apoptosis (Joseph, Cepica et al. 
2004). 
 
Studies of ISAV-induced apoptosis may provide a clearer picture of the cellular 
mechanisms of viral persistence and pathogenesis in ISAV infection.  
In the present study we wanted to investigate the effect of ISAV infection on the expression 
of apoptosis related genes in Atlantic salmon (Salmo Salar L.) cells. By using a quantitative 
real-time PCR approach we analyzed the regulation of key apoptosis related genes during 
ISAV infection in vitro. Two different permissive fish cell lines for ISAV were used in this 
study, Atlantic salmon head kidney (ASK) cells (Rolland, Bouchard et al. 2005) and salmon 
head kidney (SHK-1) cells (Dannevig, Falk et al. 1995), which are macrophage-like cell lines 
in which virus replicates with production of cytopathic effect (CPE).  
 
 Both ASK and SHK cells were infected with a low MOI (0,025) of ISAV and may 
have caused infection in relatively few cells initially. This implied that the increase in viral 
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mRNA results from increased transcription in these few cells. Because of this some of the 
initial changes in transcriptional activity in the cells analyzed might reflect cell responses to 
interferon signalling and not virus effects. However, in the late phase of the infection we 
could see an increased viral transcription (200-fold at day 7 p.i) and there was a clear shut-off 
of cellular RNA synthesis induced by ISAV. Based on this, and to make sure the RNA shut-
off not had gone too far, we decided to analyze our data from the viral infections at day 7 p.i.  
 
 The ideal reference gene should be expressed in an unchanging fashion regardless off 
experimental conditions, including different tissues or cell types, developmental stage, or 
sample treatment. Because there is no one gene that meets this criterion for every 
experimental condition, it is necessary to validate the expression stability of a control gene for 
the specific requirements of an experiment prior to its use for normalization (Wong and 
Medrano 2005). The reference gene used in this study, EF1-α, has already been validated for 
real-time PCR reaction studies in Atlantic salmon (Jorgensen, Kleveland et al. 2006). A 
previous study (Jorgensen, Lyng-Syvertsen et al. 2006) has shown that the relative expression 
levels of EF1-α during infection were 2,5-5,5 fold down regulated, at day 7 p.i, due to the 
mRNA shut-off by ISAV. This means that by normalizing data using EF1-α as a reference 
gene we can estimate the virus-induced effect on target genes relative to the housekeeping 
transcriptome. In other words, a target gene that is less down regulated than the reference 
gene, when normalized against the reference gene, can be considered up regulated.  
 
As expected, a strong IFN-α response was observed in both ASK and SHK cells in 
response to the ISAV infection, in line with observations from other salmon cell lines (Jensen, 
Albuquerque et al. 2002). In light of the low MOI used, this rapid and strong induction of IFN 
and the resulting induction of Mx demonstrated high sensitivity for low doses of viral RNA. 
 Previous infection studies with influenza A virus, have also demonstrated an early up 
regulation of IFN- inducible genes even at a MOI of 0,1, suggesting that the expression of  
these genes may be important in initiating the cascade of an antiviral response (Tong, Long et 
al. 2004). 
No antiviral effect of Mx was evident in either ASK or SHK cells and the transcription 
of ISAV mRNA (segment 5) increased steadily (figure 7.5) throughout the infection despite 
of elevated Mx mRNA levels (figure 7.10 and 7.14). In addition, mRNA shut-off was 
increasing, indicating that IFN and Mx were unable to block viral replication and recover host 
cell RNA synthesis. This supports previous reports and no antiviral effect of Mx has so far 
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been demonstrated against ISAV in Atlantic salmon cells (Jensen and Robertsen 2002), in 
contrast to what has been observed in Chinook salmon CHSE cells (Kibenge, Munir et al. 
2005).  
 
 The IAP-family and their ability to inhibit apoptosis has been reviewed in (Deveraux 
and Reed 1999). First discovered in bacloviruses, IAPs were shown to be involved in the 
suppression of the host cell death response to viral infection (Crook, Clem et al. 1993). 
cIAP, which is a gene encoding the inhibitor of apoptosis protein,  was also up regulated in 
both cell lines in response to ISAV infection. A slight up regulation of some genes in the IAP-
family have also been demonstrated during influenza A infection, but then at a MOI of 1,0 
(Tong, Long et al. 2004). 
Apoptosis is mainly thought to be a process initiated by the host cell to limit the time 
and cellular machinery available for viral replication (Thompson 1995). Many RNA viruses, 
including ISAV (Joseph, Cepica et al. 2004), are known to induce apoptosis under conditions 
which allow efficient virus multiplication (i.e, a permissive infection). A study  (Koyama, 
Fukumori et al. 2000) demonstrated that, by rapid multiplication, influenza viruses and 
probably many other RNA viruses are able to complete viral replication long before the onset 
of virus induced apoptosis, and thereby cause a permissive infection.  
The up regulation of cIAP, as a result of the ISAV infection, might therefore be a 
mechanism by which the virus post-pone the apoptotic process in the host cell, to ensure more 
time for viral replication.     
Adenoviruses have previously been shown to delay apoptosis in cerebellar granule 
neurons, through actions involving IAPs (Simons, Beinroth et al. 1999). 
 
 The ASK cells also showed a tendency to up regulate the expression of caspase 3. This 
was not observed in the SHK-1 cell line.  
Caspase is a central player in apoptosis regulation and its activity is often measured to 
determine the impact of a given apoptotic stimulus (Watanabe, Hitomi et al. 2002). A recent 
study demonstrated that caspase-3 activation is essential for influenza A virus propagation in 
cell cultures (Wurzer, Planz et al. 2003). On the other hand, Joseph et al. (2004) has studied 
ISAV-induced apoptosis and suggested that ISAV-induced apoptosis in SHK-1 cells occurs 
via the caspase-activation pathway, but may not involve activation of caspase-3. If our results 
show an up regulation of caspase-3 in ASK cells or if the up regulation is due to personal 
errors, is hard to say.  
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 Even though one genes expression is up regulated, it might not have a biological effect 
on the cell, as it is the proteins that exert the effects in a cell. Caspases and p53 are for 
example thought to have a constant expression in the cell, and is mainly regulated at the 
protein level through switching form an inactivated to an activated state (Alberts, Johnson et 
al. 2002). All these results therefore, only give indications of what the cell responses are to the 
viral infection. 
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9. CONCLUSION 
 
 
 In this study, were we investigated the gene expression of several apoptosis related 
genes in response to ISAV infection, our results strongly indicate an up regulation of IFN-α, 
Mx and cIAP-1, in both ASK and SHK-1 cell lines.  
In light of the low MOI used in this study, the rapid and strong induction of IFN-α 
demonstrates that the cells are highly sensitive to low doses of viral RNA.  
Our results also show that the strong induction of IFN-α and Mx does not affect the 
transcription of viral mRNA, as it increased steadily throughout the infection. This indicates 
that these genes have little or no antiviral effect against ISAV in Atlantic salmon cells. 
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